Intestinal Microsporidiosis in French Heart Transplant Recipients (CARMIC)
Recruiting
Observational Study
Microsporidiosis Intestinal
Heart Transplant Infection
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Sex
- Any
- Study type
- Observational
- Participants needed
- 39 (estimated)
- Sponsor
- University Hospital, Clermont-Ferrand · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The investigators propose to carry out a national retrospective study to collect epidemiological, biological, clinical and therapeutic data on microsporidiosis among heart transplant patients.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* heart transplant patients diagnosed with intestinal microsporidiosis
* diagnosis made before December 31, 2024 in France (metropolitan France and overseas territories)
Exclusion Criteria:
-patient opposition
Contacts